The stock of Generation Bio Co (GBIO) has seen a -0.65% decrease in the past week, with a -37.87% drop in the past month, and a -60.06% decrease in the past quarter. The volatility ratio for the week is 14.01%, and the volatility levels for the past 30 days are at 9.45% for GBIO. The simple moving average for the past 20 days is -19.82% for GBIO’s stock, with a -71.65% simple moving average for the past 200 days.
Is It Worth Investing in Generation Bio Co (NASDAQ: GBIO) Right Now?
Company’s 36-month beta value is 2.68.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for GBIO is 45.64M, and currently, short sellers hold a 5.04% ratio of that floaft. The average trading volume of GBIO on February 21, 2025 was 481.50K shares.
GBIO) stock’s latest price update
Generation Bio Co (NASDAQ: GBIO) has experienced a decline in its stock price by -6.35 compared to its previous closing price of 0.66. However, the company has seen a fall of -0.65% in its stock price over the last five trading days. businesswire.com reported 2025-02-06 that MUNICH, Germany–(BUSINESS WIRE)–Tubulis today announced the appointment of Matthew Norkunas, MD, MBA, as Chief Financial Officer (CFO) and President of Tubulis Inc., further strengthening its management team at a pivotal stage of growth. Dr. Norkunas’ proven track record of achieving financial and corporate goals for rapidly evolving biotechs will be instrumental in advancing Tubulis’ strategic objectives. His unique background as a physician-turned-business executive will support the company.
Analysts’ Opinion of GBIO
Canaccord Genuity, on the other hand, stated in their research note that they expect to see GBIO reach a price target of $9. The rating they have provided for GBIO stocks is “Buy” according to the report published on November 08th, 2022.
GBIO Trading at -35.43% from the 50-Day Moving Average
After a stumble in the market that brought GBIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.77% of loss for the given period.
Volatility was left at 9.45%, however, over the last 30 days, the volatility rate increased by 14.01%, as shares sank -35.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -51.95% lower at present.
During the last 5 trading sessions, GBIO fell by -0.65%, which changed the moving average for the period of 200-days by -80.23% in comparison to the 20-day moving average, which settled at $0.7670. In addition, Generation Bio Co saw -41.98% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GBIO starting from Quinn Anthony G., who purchase 125,791 shares at the price of $0.96 back on Jan 10 ’25. After this action, Quinn Anthony G. now owns 214,286 shares of Generation Bio Co, valued at $120,759 using the latest closing price.
Quinn Anthony G., the Director of Generation Bio Co, purchase 85,000 shares at $0.97 during a trade that took place back on Jan 13 ’25, which means that Quinn Anthony G. is holding 299,286 shares at $82,450 based on the most recent closing price.
Stock Fundamentals for GBIO
Current profitability levels for the company are sitting at:
- -5.3 for the present operating margin
- 0.76 for the gross margin
The net margin for Generation Bio Co stands at -7.83. The total capital return value is set at -0.45. Equity return is now at value -86.50, with -46.16 for asset returns.
Based on Generation Bio Co (GBIO), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at -1.04. The debt to equity ratio resting at 0.9. The interest coverage ratio of the stock is -6.13.
Currently, EBITDA for the company is -133.3 million with net debt to EBITDA at -0.78. When we switch over and look at the enterprise to sales, we see a ratio of 6.09. The receivables turnover for the company is 8.4for trailing twelve months and the total asset turnover is 0.07. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.34.
Conclusion
In a nutshell, Generation Bio Co (GBIO) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
